PubMed:25839646 / 760-914
Annnotations
GoldHamster
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T83 | 0-4 | UBERON:0000965 | denotes | Lens |
| T84 | 0-4 | UBERON:0005389 | denotes | Lens |
| T85 | 5-13 | D002214 | denotes | capsules |
| T87 | 32-35 | PR:Q8CFD5 | denotes | CsA |
| T88 | 32-35 | PR:000007170 | denotes | CsA |
| T90 | 32-35 | P08796 | denotes | CsA |
| T91 | 32-35 | PR:Q13216 | denotes | CsA |
| T89 | 32-35 | CHEBI:55379 | denotes | CsA |
| T86 | 32-35 | D003057 | denotes | CsA |
| T93 | 149-153 | CHEBI:23888 | denotes | drug |
PubMed_ArguminSci
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T5 | 0-154 | DRI_Approach | denotes | Lens capsules were treated with CsA for 1, 2, 3, 4, 5, 6, or 7 days, and subsequently maintained in culture for a total of 28 days in the absence of drug. |
Goldhamster2_Cellosaurus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 40-47 | CVCL_HE67|Factor-dependent_cell_line|Mus musculus | denotes | 1, 2, 3 |
| T12 | 49-53 | CVCL_E420|Transformed_cell_line|Homo sapiens | denotes | 4, 5 |
| T13 | 55-60 | CVCL_VN30|Cancer_cell_line|Homo sapiens | denotes | 6, or |
| T14 | 112-113 | CVCL_6479|Finite_cell_line|Mus musculus | denotes | a |